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Background: Japanese encephalitis virus (JEV) is the etiological agent of Japanese encephalitis (JE), one of the
most serious viral encephalitis worldwide. Five genotypes have been classified based on phylogenetic analysis of
the viral envelope gene or the complete genome. Previous studies based on four genotypes have reported that in
evolutionary terms, genotype 1 JEV is the most recent lineage. However, until now, no systematic phylogenetic
analysis was reported based on whole genomic sequence of all five JEV genotypes.
Findings: In this study, phylogenetic analysis using Bayesian Markov chain Monte Carlo simulations was conducted
on the whole genomic sequences of all five genotypes of JEV. The results showed that the most recent common
ancestor (TMRCA) for JEV is estimated to have occurred 3255 years ago (95% highest posterior density [HPD], −978
to−6125 years). Chronologically, this ancestral lineage diverged to produce five recognized virus genotypes in the
sequence 5, 4, 3, 2 and 1. Population dynamics analysis indicated that the genetic diversity of the virus peaked
during the following two periods: 1930–1960 and 1980–1990, and the population diversity of JEV remained
relatively high after 2000.
Conclusions: Genotype 5 is the earliest recognized JEV lineage, and the genetic diversity of JEV has remained high
since 2000.
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Japanese encephalitis virus (JEV) is the prototype mem-
ber of the JEV serogroup within the genus Flavivirus,
family Flaviviridae. JEV comprises five genotypes (G1-G5)
[1-3]. In previous studies, the phylogenetic characteristics
of JEV were analyzed and the most recent common ances-
tor (TMRCA) was estimated. The TMRCA of JEV was es-
timated to be 1690 years when calculations were based on
the complete sequence of four genotypes (G1-G4) [4],
whereas, analysis of JEV using a limited number of whole
genomic sequences from five genotypes indicated that* Correspondence: gdliang@hotmail.com
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More recently, however, G5 strain XZ0934 isolated in
2009, which had not been included in earlier analyses, was
shown to be significantly different from the G5 Muar iso-
late [6]. Therefore, in order to improve our understanding
of the evolutionary progress and population diversity of
JEV, a comprehensive dataset was established for evolu-
tionary analysis of JEV in this study. In the dataset, 100
whole genomic sequences of JEV representing all five ge-
notypes of JEV, isolated from various hosts (humans, pigs
and bats) and vectors (mosquitoes and midges) were col-
lected and analyzed.
Two G5 JEV full-length genome sequences (Muar and
XZ0934) were downloaded from GenBank (GB No.
HM596272 and JF915894, respectively) and added to the
database established in a previous report [4], forming a
new database for analysis (Table 1). The new JEV se-
quence database was analyzed using Bayesian Markov
chain Monte Carlo (MCMC) method. The General Timeis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Table 1 Information of JEV isolates analyzed in this study
Strain Date Country Hosta Genotype GenBank accession no.
47 1950’s China:Heilongjiang CSF 3 JF706269
14178 2001 India - 3 EF623987
57434 2005 India - 3 EF623988
04940-4 2002 India - 3 EF623989
B58 1989 China:Yunnan Bat 3 FJ185036
Beijing-1 1949 China Human brain 3 L48961
BL06-50 2006 China:Guangxi Culex tritaeniorhynchus 1 JF706270
BL06-54 2006 China:Guangxi Culex tritaeniorhynchus 1 JF706271
CBH 1954 China:Fujian CSF 3 JN381860
CH-13 1957 China:Sichuan CSF 3 JN381870
CH1392 1990 Taiwan Culex tritaeniorhynchus 3 AF254452
CTS 1955 China:Fujian CSF 3 GQ429184
CZX 1954 China:Fujian CSF 3 JN381865
DH107 1989 China:Yunnan Aedes lineatopennis 3 JN381873
DL04-29 2004 China:Yunnan Culex theileri 3 JF706272
DL04-45 2004 China:Yunnan Ar. Subalbatus & Mansonia uniform 3 JN381854
Fj02-29 2002 China:Fujian CSF 3 JF706273
Fj02-76 2002 China:Fujian Human blood 3 JN381867
FJ03-39 2003 China:Fujian Human blood 3 JN381859
FJ03-94 2003 China:Fujian Human blood 3 JN381858
FU 1995 Australia Human serum 2 AF217620
G35 1954 China:Fujian Mosquito pool 3 GQ429185
GB30 1997 China:Yunnan Murina aurata brain tissue 3 FJ185037
GP78 1978 India Human brain 3 AF075723
GS07-TS11 2007 China:Gansu Culex tritaeniorhynchus 1 JN381843
GSBY0801 2008 China:Gansu Culex tritaeniorhynchus 1 JF706274
GSBY0804 2008 China:Gansu Culex tritaeniorhynchus 1 JN381844
GSBY0810 2008 China:Gansu Culex tritaeniorhynchus 1 JN381840
GSBY0816 2008 China:Gansu Culex tritaeniorhynchus 1 JN381842
GSBY0827 2008 China:Gansu Culex tritaeniorhynchus 1 JN381845
GSBY0861 2008 China:Gansu Culex tritaeniorhynchus 1 JN381833
GSS 1960’s China:Beijing CSF 3 JF706275
GX0519 2005 China:Guanxi Culex tritaeniorhynchus 1 JN381835
GX0523/44 2005 China:Guanxi Culex tritaeniorhynchus 1 JN381832
GZ04-2 2004 China:Guizhou Armigeres 3 JN381857
GZ56 2006 China:GuiZhou CSF 1 HM366552
Ha-3 1960’s China:Heilongjiang CSF 3 JN381872
HB49 1990 China:Yunnan Rousettus leschenaulti blood 3 JF706284
HB97 1990 China:Yunnan Rousettus leschenaulti blood 3 JF706285
HLJ02-134 2002 China:Heilongjiang Genus culicoides 3 JF706276
HN04-11 2004 China:Henan Culex 1 JN381831
HN04-21 2004 China:Henan Culex 1 JN381841
HN06129 2006 China:Henan Armigeres 1 JF706277
HN0621 2006 China:Henan Culex 1 JN381830
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Table 1 Information of JEV isolates analyzed in this study (Continued)
HN0626 2006 China:Henan Culex 1 JN381837
HVI 1965 Taiwan Mosquito 3 AF098735
HYZ 1979 China:Yunnan Patient blood 3 JN381853
Ishikawa 1994 Japan Culex tritaeniorhynchus 1 AB051292
JaGAr 01 1959 Japan Cluex 3 AF069076
JaOArS982 1982 Japan Mosquito 3 M18370
JaOH0566/Japan/1966/human 1966 Japan Human 3 AY508813
JEV/sw/Mie/40/2004 2004 Japan Swine serum 1 AB241118
JEV/sw/Mie/41/2002 2002 Japan Swine serum 1 AB241119
JH04-18 2004 China:Yunnan Whitmorei & Anophelessinensis 3 JN381855
JKT6468 1981 Indonesia Mosquito 4 AY184212
K87P39 1987 South Korea Mosquito 3 AY585242
KV1899 1999 Korea Swine 1 AY316157
LFM 1955 China:Fujian Human blood 3 JN381863
Ling 1965 Taiwan Human brain 3 L78128
LN02-102 2002 China:liaoning Culex modestus 1 JF706278
LN0716 2007 China:Liaoning Culex tritaeniorhynchus 1 JN381849
LYZ 1957 China:Fujian CSF 3 JN381869
M28 1977 China:Yunnan Culex pseudovishnui 1 JF706279
Nakayama 1935 Japan Human brain 3 EF571853
P3 1949 China:Beijing Human brain 3 U47032
RP-2 ms 1985 Taiwan Mosquito 3 AF014160
RP-9 1985 Taiwan Mosquito 3 AF014161
SA14 1954 China Mosquito 3 U14163
SC04-12 2004 China:Sichuan Culex 1 JN381839
SC04-15 2004 China:Sichuan Culex tritaeniorhynchus 1 JN381838
SD0810 2008 China:Shandong Culex tritaeniorhynchus 1 JF706286
SH03-103 2003 China:Shanghai Culex tritaeniorhynchus 1 JN381847
SH03-105 2003 China:Shanghai Culex tritaeniorhynchus 1 JN381846
SH04-10 2004 China:Shanghai Culex tritaeniorhynchus 3 JN381856
SH04-5 2004 China:Shanghai Culex tritaeniorhynchus 3 JN381866
SH17M-07 2007 China - 1 EU429297
SH-3 1987 China:Shanghai CSF 3 JN381864
SH-53 2001 China:Shanghai Culex tritaeniorhynchus 1 JN381850
SH-80 2001 China:Shanghai Culex tritaeniorhynchus 1 JN381848
T1P1 1997 Taiwan Armigeres subalbatus 3 AF254453
TLA 1971 China:Liaoning CSF 3 JN381868
Vellore P20778 1958 India Human brain 3 AF080251
XJ69 2007 China Culex pipiens pallens 1 EU880214
XJP613 2007 China Culex tritaeniorhynchus 1 EU693899
XZ0938 2009 China:Xizang Culex tritaeniorhynchus 1 HQ652538
YLG 1955 China:Fujian CSF 3 JF706280
YN 1954 China:Yunnan CSF 3 JN381871
YN05124 2005 China:Yunnan Culex tritaeniorhynchus 1 JF706281
YN05155 2005 China:Yunnan Culex tritaeniorhynchus 1 JN381852
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YN0623 2006 China:Yunnan Culex tritaeniorhynchus 1 JN381836
YN0911 2009 China:Yunnan Culex tritaeniorhynchus 1 JF706267
YN0967 2009 China:Yunnan Culex tritaeniorhynchus 1 JF706268
YN79-Bao83 1979 China:Yunnan Culex tritaeniorhynchus 1 JN381851
YN82-BN8219 1982 China:Yunnan Mosquito 1 JN381834
YN83-Meng83-54 1983 China:Yunnan Lasiohelea taiwana Shiraki 1 JF706282
YN98-A151 2003 China:Yunnan Mosquitoes 3 JN381861
ZMT 1955 China:Fujian CSF 3 JF706283
ZSZ 1955 China:Fujian CSF 3 JN381862
Muar 1952 Malaysia Human brain 5 HM596272
XZ0934 2009 China:Tibet Culex tritaeniorhynchus 5 JF915894
a- Information not available.
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model was selected using MrModelTest [7]. The nu-
cleotide substitution rates and divergence times of the
most recent common ancestor (TMRCA) were esti-
mated using the relaxed (uncorrelated lognormal) mo-
lecular clock model in the BEAST software package [8].
Demographic histories of JEV were inferred based on
Bayesian skyline reconstruction. The analysis was run
through 1,000,000,000 generations to ensure sufficient






Figure 1 Maximum clade credibility (MCC) tree for 100 whole-genom
G2 (yellow), G3 (blue), G4 (green) and G5 (orange). Estimated TMRCAs of th
G1: 155(104–315), G2: 530(235–1131), G3: 880(420–1855), G4: 1653(765–337tree was built using TreeAnnotator with 10% burn-in
(http://beast.bio.ed.ac.uk/).
Based on Bayesian Markov chain Monte Carlo (MCMC)
analysis, the maximum clade credibility (MCC) tree for
the whole genomic sequences of JEV was established
(Figure 1). Representatives of the five distinct lineages
were included in the analysis. The posterior probability
values for the nodes of each lineage were >0.95, indicating
their robustness. JEV was estimated to have emerged













e sequences of JEV. Five distinct lineages were identified: G1 (red),
ese lineages (with their 95% HPD values in parentheses) are shown,
2), and G5: 3255(978–6125).
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recognized genotypes. In chronological order, they di-
verged in the order G5, G4, G3, G2 and G1. Thus, G5 rep-
resents the most ancestral lineage among genotypes 1–5.
The mean rate of nucleotide substitution for the whole
genomic sequences of 100 JEV strains isolated from a
variety of hosts worldwide, estimated using a Bayesian
MCMC approach, was 1.01 × 10−4 nucleotide substitu-
tions per site per year (95% HPD values, 4.37 × 10−5,
1.56 × 10−4). This is similar to previous estimates based
on analysis of four JEV genotypes [4].
The population dynamics of JEV are shown in Figure 2.




























Figure 2 Bayesian skyline plots for JEV. Highlighted areas correspond to
history; (B) Populations during the later evolutionary history since 1800.experienced complicated changes during the process of
evolution. However, the virus population remained rela-
tively stable during the first 2700 years (Figure 2A),
followed by a period of rapid decline from the 1700s,
reaching a minimum in the 1900s. It then increased rap-
idly from the 1930s until the 1960s and formed the first
peak. The second peak appeared in the 1980-1990s and
subsequently the populations of JEV remained high after
2000 (Figure 2B).
The findings in this study have similarities with previ-
ous studies [5]. For example, the divergence pattern of
the genotypes occurred in the order G5, G4, G3, G2 and
G1, and the mean rate of nucleotide substitution was95% HPD intervals. (A) Populations during the whole evolutionary
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time of TMRCA determined in this study (~3255 years
ago) was quite different compared with that measured in
the report (~460 years ago) of Mohammed et al. [5].
The reason for this discrepancy could be attributed to
the dataset used for analysis. In Mohammed’s study,
only 35 whole genomic sequences were used and the
only G5 representative included was the Muar strain.
Therefore, since our new dataset includes two G5 rep-
resentatives with robust sequences, the occurrence time
of TMRCA (~3255 years ago) obtained in this study
should reflect more precisely the evolutionary patterns
and diversity of JEV.
Two main peak periods in population dynamics were
identified in this study, 1930–1960 and 1980-1990s, re-
spectively. These fluctuations were reflections of the
virus activity in the sylvatic environment. Since the
1930s, JEV strains belonging to G3 emerged and were
isolated from Asian countries. G5 was first identified in
1952 [2,4]. This was a good interpretation of the first
peak. Subsequently, G2 and G4 strains were isolated
during the 1980s. Importantly, the G1 genotype emerged
during the 1980s onwards [4]. Therefore, the virus popu-
lation diversity peaked in the 1980-1990s. Since 2000,
G1 JEV has become the dominant genotype in most en-
demic regions [4], and although a relatively small de-
crease was observed, the virus remains the most active
and G5 reemerged.
Interestingly, although G5 is estimated to be the most
ancestral JEV lineage, this virus showed a highly active
dispersal capacity following its reemergence. Indeed, this
new G5 strain was isolated from mosquitoes collected in
southern region of the Asian continent (Tibet, China) in
2009 [2] and northeast region of Asia (South Korea) dur-
ing the same year [9]. Thus, G5 now appears to be dis-
persing widely in Asia. A recent study showed that
genotype 1 JEV originated in Southeastern Asia and
spread to the entire Asian continent [10]. Based on these
observations, it seems likely that G5 will follow a disper-
sal pattern similar to that of G1 JEV, and has dispersed
or will disperse over the entire Asian continent. Clearly,
G5 should be monitored closely throughout JEV en-
demic regions.
Finally, the available inactivated and live attenuated JE
vaccines are derived from G3 JEVs [11]. Thus, the level
of cross protection of the current vaccines against G5
JEV is likely to be sub-optimal and should therefore be
analyzed carefully since the reemergence of G5 and its
widespread dispersal, and significant genetic variation
could impact on its epidemiology. This possibility is em-
phasized by the fact that Muar (the first G5 JEV) strain
was isolated from a patient with severe viral encephalitis
[12]. Thus, there is the realistic possibility that the newly
isolated G5 viruses could be highly virulent. Thus, thepotential disease burden of viral encephalitis caused by
G5 JEV requires careful reassessment.
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